WO2023105303 - COMPOUNDS FOR THE TREATMENT OF CANCER
National phase entry:
Publication Number
WO/2023/105303
Publication Date
15.06.2023
International Application No.
PCT/IB2022/054955
International Filing Date
26.05.2022
Title **
[English]
COMPOUNDS FOR THE TREATMENT OF CANCER
[French]
COMPOSÉS POUR LE TRAITEMENT DU CANCER
Applicants **
KASHIV BIOSCIENCES, LLC
20, New England Avenue
Piscataway, New Jersey 08854, US
Inventors
PUROHIT, Parva Yogeshchandra
F-204, Satyamev vista, Nr. Gota over bridge, S.G.Highway, Gota, Ahmedabad, Gujarat
Ahmedabad 382481, IN
GOSWAMI, Vishalgiri Gunvantgiri
163, Tarangahill society, Ahmedabad, Gujarat
Ahmedabad 382481, IN
MEHTA, Chirag Chimanlal
401, Satya Arth Apt, 14, Shrenik Society, Ahmedabad, Gujarat
Ahmedabad 380013, IN
BARMADE, Mahesh Angadrao
26/27, Behind Adat line, Shivaji Nagar, Nilanga; Dist: Latur, Maharashtra
Nilanga 413521, IN
SANGLE, Ganesh Vishwanath
991, Kumar Plot, Dusarbid, Dist - Buldhana, Maharashtra
Dusarbid 443308, IN
UNADKAT, Vishal Bharatbhai
D-803, Gala Marigold, Ahmedabad, Gujarat
Ahmedabad 380058, IN
VARIYA, Ketan Gordhanbhai
68, Nilkanth Society-1, Katargam, Surat, Gujarat
Surat 395004, IN
PANDYA, Heta Nishil
A-12, Paras bunglows 1, Ahmedabad, Gujarat
Ahmedabad 380015, IN
Priority Data
202121056647
06.12.2021
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 4624 | |
| EPO | Filing, Examination | 50226 | |
| Japan | Filing | 591 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 24480 |
Total: 80496 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to novel compounds or pharmaceutically acceptable salts thereof, useful for the treatment of cancer. The present disclosure also relates to pharmaceutical composition of the novel compound and method of treating benign or malignant disease of the breast or reproductive tract, prostate cancer, or endometrial cancer using the same.[French]
La présente invention concerne de nouveaux composés ou des sels pharmaceutiquement acceptables de ceux-ci, utiles pour le traitement du cancer. La présente divulgation concerne également une composition pharmaceutique du nouveau composé et une méthode de traitement d'une maladie bénigne ou maligne du sein ou du tractus reproducteur, du cancer de la prostate ou du cancer de l'endomètre l'utilisant.